- Home
- Free App Analytics
- Focus On Lymphoma
- Focus On Lymphoma Vs. Updates in NHL Management
Focus On Lymphoma vs Updates in NHL Management Usage & Stats
Focus on Lymphoma provides comprehensive information and tools to patients and caregivers to help them understand their lymphoma diagnosis and manage their cancer treatment. The app provides the most up-to-date information and resources on lymphoma from the Lymphoma Research Foundation.
- Comprehensive and disease-specific information tailored to your lymphoma subtype
- Unique tools designed specifically to help manage a lymphoma diagnosis including a medication tracker, blood counts tracker, and symptoms tracker
- Keep track of doctor appointments, questions to ask your doctor, and record sessions
- Access to the LRF Helpline and free support services including clinical trial searchers, peer support, financial assistance, and more.
- Learn about and prepare for the chimeric antigen receptor (CAR) T-cell therapy process.
For more detailed information, visit https://lymphoma.org/mobileapp.
- Apple App Store
- Free
- Medical
Store Rank
- -
In the management of non-Hodgkin lymphoma (NHL), multiple mechanisms of therapy have been developed. These therapies include anti-CD20 antibodies and chimeric antigen receptor T-cell (CAR-T) therapies. With continued developments in NHL management, bispecific antibodies are a promising strategy for use in the relapsed/refractory setting with promising data showing potential for improving outcomes in patient care.
- Apple App Store
- Free
- Medical
Store Rank
- -
Focus On Lymphoma vs. Updates in NHL Management ranking comparison
Compare Focus On Lymphoma ranking trend in the past 28 days vs. Updates in NHL Management
Rank
No Data Available
Focus On Lymphoma vs. Updates in NHL Management ranking by country comparison
Compare Focus On Lymphoma ranking trend in the past 28 days vs. Updates in NHL Management
No Data to Display
Compare to any site with our free trial
Focus On Lymphoma VS.
Updates in NHL Management
December 30, 2024